hero image
Ibrahim Nassour - University of Florida. Gainesville, FL, US

Ibrahim Nassour

Assistant Professor | University of Florida

Gainesville, FL, UNITED STATES

Dr. Ibrahaim Nassour specializes in surgeries for cancers of the gastrointestinal tract, pancreas, liver and bile duct.


Dr. Ibrahim Nassour, M.D., M.S.C.S., is an assistant professor and surgical oncologist. At UF Health, Dr. Nassour specializes in surgeries for cancers of the gastrointestinal tract, pancreas, liver and bile duct. He has special interest in robotic pancreato-biliary surgery including robotic pancreaticoduodenectomy (Whipple procedure) and in regional therapies for metastatic disease. Dr. Nassour’s research focuses on comparative effectiveness studies that evaluate the role of minimally invasive and robotic surgery as well as the role of neoadjuvant therapy in the management of pancreato-biliary cancers. In addition, he is interested in designing clinical trials in the management of pancreato-biliary malignancies.

Areas of Expertise (20)

Peritoneal Surface Malignancy


Cytroreductive Surgery

Pancreatic Pseudocyst

Neuroendocrine Tumors

Pancreatic Cancer

Ampullary Cancer

Small Bowel Cancer


Stomach Cancer

Stomach Polyp

Duodenal Cancer

Bile Duct Cancer


Colorectal Metastasis

Pancreatic Cyst




Robotic Surgery

Media Appearances (1)

UF Health surgical oncologists perform first HIPEC procedure

UF Department of Surgery  


In December, surgeons at UF Health performed their first cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) to treat abdominal cancer in an adult patient. The surgery was successful, and the patient has been discharged and seen in clinic during the postoperative follow up.

view more


Articles (3)

National adoption of neoadjuvant chemotherapy: paradigm shift in the treatment of pancreatic cancer


Ibrahim Nassour, et. al


The historical standard of care in treating operable pancreatic cancer via upfront surgery has been challenged recently using a neoadjuvant approach. The aim of the study is to examine the national practice patterns in the management of pancreatic cancer with an emphasis on the trends of neoadjuvant systemic therapy use.

view more

Novel Calculator to Estimate the Risk of Clinically Relevant Postoperative Pancreatic Fistula Following Distal Pancreatectomy

Journal of Gastrointestinal Surgery

Ibrahim Nassour, et. al


Drain management algorithms are based on studies that predict clinically relevant postoperative pancreatic fistula (CR-POPF) using drain fluid amylase level on POD1 (DFA1). These studies are focused on pancreaticoduodenectomy which is inherently different than distal pancreatectomy. Moreover, the change of DFA between POD1 and POD3 (ΔDFA) is underutilized despite its importance in predicting CR-POPF.

view more

Minimally Invasive Techniques for Pancreatic Resection

Surgical Oncology Clinics

Ibrahim Nassour, et. al


There is increasing interest in the role of minimally invasive surgery (MIS) for pancreatectomy. Prospective data indicate significant advantages for MIS when performed for left-sided pancreatic pathologies and may be deemed as the standard of care. However, there is reluctance in implementing this technique to pancreaticoduodenectomy because of the complexity of the operation and the mixed results from randomized trials.

view more





loading image